Compare · PLUS vs WGS
PLUS vs WGS
Side-by-side comparison of ePlus inc. (PLUS) and GeneDx Holdings Corp. (WGS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both PLUS and WGS operate in Retail: Computer Software & Peripheral Equipment (Technology), so they compete in similar markets.
- PLUS is the larger of the two at $2.15B, about 1.4x WGS ($1.55B).
- Over the past year, PLUS is up 13.5% and WGS is down 27.8% - PLUS leads by 41.3 points.
- PLUS has been more active in the news (6 items in the past 4 weeks vs 3 for WGS).
- WGS has more recent analyst coverage (8 ratings vs 3 for PLUS).
- Company
- ePlus inc.
- GeneDx Holdings Corp.
- Price
- $82.25+1.77%
- $52.31-7.04%
- Market cap
- $2.15B
- $1.55B
- 1M return
- -1.41%
- +51.05%
- 1Y return
- +13.51%
- -27.76%
- Industry
- Retail: Computer Software & Peripheral Equipment
- Retail: Computer Software & Peripheral Equipment
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1996
- 2020
- News (4w)
- 6
- 3
- Recent ratings
- 3
- 8
ePlus inc.
ePlus inc., through its subsidiaries, provides information technology solutions that enable organizations to optimize their information technology (IT) environment and supply chain processes in the United States. It operates in two segments, Technology and Financing. The Technology segment offers hardware, perpetual and subscription software, maintenance, software assurance, and internally-provided and outsourced services; and professional and managed services, including ePlus managed, professional, security, ePlus Cloud Consulting, staff augmentation, server and desktop support, and project management services. The Financing segment specializes in leasing and financing arrangements, such as sales-type and operating leases; loans and consumption-based financing arrangements; and underwriting and management of IT equipment and assets. Its financing operations comprise sales, pricing, credit, contracts, accounting, risk management, and asset management. This segment primarily finances IT, communication-related, and medical equipment; and industrial machinery and equipment, office furniture and general office equipment, transportation equipment, and other general business equipment directly, as well as through vendors. ePlus inc. serves commercial entities, state and local governments, government contractors, and educational institutions. The company was formerly known as MLC Holdings, Inc. and changed its name to ePlus inc. in 1999. ePlus inc. was founded in 1990 and is headquartered in Herndon, Virginia.
Latest PLUS
- ePlus Demonstrates Enterprise-Grade Agentic AI Platform for Autonomous IT and Security Operations at Cisco Live
- SEC Form 10-K filed by ePlus inc.
- ePlus inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
- ePlus Reports Fourth Quarter and Fiscal Year 2026 Financial Results
- ePlus Launches Private AI Infrastructure Managed Service
- ePlus Announces Fourth Quarter and Fiscal Year 2026 Earnings Release Date and Conference Call
- CHIEF OPERATING OFFICER Raiguel Darren S sold $115,314 worth of shares (1,284 units at $89.81) as part of a pre-agreed trading plan (SEC Form 4)
- CHIEF OPERATING OFFICER Raiguel Darren S sold $440 worth of shares (5 units at $88.00) as part of a pre-agreed trading plan (SEC Form 4)
- ePlus Unveils Dynamic New ePlus.com Website Focusing on Customer Journeys
- ePlus Launches Memory Optimization and Reclamation Assessment to Help Organizations Mitigate Chip Shortages
Latest WGS
- CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 717 shares and sold $19,092 worth of shares (369 units at $51.74), increasing direct ownership by 1.00% to 35,290 units (SEC Form 4) to cover taxes
- GeneDx to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
- Director Casdin Capital, Llc bought $21,459,736 worth of shares (500,000 units at $42.92) (SEC Form 4)
- Director Meister Keith A. bought $13,765,345 worth of shares (351,273 units at $39.19) (SEC Form 4)
- Director Meister Keith A. bought $46,806,729 worth of shares (1,205,147 units at $38.84) (SEC Form 4)
- SEC Form 4 filed by Director Casdin Capital, Llc
- SEC Form 10-Q filed by GeneDx Holdings Corp.
- GeneDx Holdings Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- GeneDx Reports First Quarter 2026 Financial Results and Updates Full-Year Outlook
- CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 3,874 shares and sold $141,595 worth of shares (2,172 units at $65.19), increasing direct ownership by 2% to 93,216 units (SEC Form 4) (for tax liability)